Skip to main content
Industry News
US to send remdesivir to states seeing COVID-19 surge

HHS announced plans to send the remainder of the antiviral drug remdesivir from the national stockpile to states experiencing a surge of COVID-19 cases, including Arizona, California, Florida and Texas. HHS said it would work with Gilead Sciences, the maker of remdesivir, to determine how additional expected doses will be allocated.

Full Story: